New protein from geothermal microorganism could aid fight against antimicrobial resistance
Scientists in New Zealand have used genomic mining to discover a new protein that could have antimicrobial properties.
Antimicrobial resistance is one of the biggest threats to global health and the race is on to find new molecules with antibiotic properties. One way scientists try to find these molecules is to study proteins produced by microorganisms themselves, as the bacteria often uses these to fight off other competing bugs.
Scientists analyse the microorganism’s genetic make-up – its genome – looking for sequences of code that correspond to types of proteins known to have antibiotic properties. One group of such proteins are called lanthipeptides that have a particular structure known to be effective at fighting off bacteria.
Researchers in New Zealand recently applied this process, known as ‘genome mining’, to a strain of Thermogemmatispora – a type of bacteria that lives in extreme conditions in the heated soil of New Zealand’s Taupo geothermal zone. They discovered a new type of lanthipeptide, called tikitericin, which they believe is part of the microorganism’s host defence system.
“The global issue of antimicrobial resistance will affect everyone, so we need to find new solutions,” says Professor Margaret Brimble from the University of Auckland, whose research group are behind the discovery. “Naturally occurring antimicrobial peptides, produced by microorganisms to fend off other microorganisms, are a rich source of lead compounds to develop new antibiotics.”
Other lanthipeptides have already shown evidence of antimicrobial properties, and one has even been approved as food preservation agent, so Margaret’s team knew the protein they had isolated had potential. However, extracting proteins from microorganisms is time-consuming and often the yields are small. The team knew that to be able to study tikitericin in detail, they would need to develop a way to make it in the lab.
Using a number of different techniques to analyse the protein isolated from the Thermogemmatispora strain, the team were able to identify the structure of tikitericin, enabling them to build the peptide in the lab. Now that they can produce larger quantities of the molecule, the team can investigate its antimicrobial properties and hope that it will one day play a role in fighting bacterial infections.
“I am passionate about trying to understand the intricate chemistry that links organisms together,” says Dr Robert Keyzers, senior lecturer at the Victoria University of Wellington and co-author of the paper. “If we are lucky enough, one of our compounds may spearhead a greater understanding of biochemistry, metabolism or molecular biology that in the future, could lead to advances in medicine. One day a molecule we discover may help some sick people somewhere and that is a legacy we would all be amazingly proud of.”
This article is free to read in our open access, flagship journal Chemical Science: Buzhe Xu et al., Chem. Sci., 2018, Accepted Manuscript. DOI: 10.1039/C8SC02170H. You can access all of our ChemSci Picks in this article collection.
ChemSci Pick of the Week
Chemical Science is the flagship journal of the Royal Society of Chemistry and publishes findings of exceptional significance from across the chemical sciences. It is a global journal for the discovery and reporting of breakthroughs in basic chemical research, communicated to a worldwide audience without barriers, through open access. All article publication charges have been waived, meaning that the journal is free to read and free to publish.
Every Wednesday we are sharing one story from Chemical Science, highlighting the cutting-edge work we publish. Follow @ChemicalScience and #ChemSciPicks on Twitter to stay up to date.
If you are a journalist wishing to receive brand new research from our journals under embargo, please contact the press office using the contact box below, to be added to our distribution list.
Press office
- Tel:
- +44 (0) 20 7440 3351
- Email:
- Send us an email